News
INMD
14.51
+0.42%
0.06
InMode's Shares Are Too Cheap To Ignore: The Bottom May Be In
Seeking Alpha · 3d ago
Weekly Report: what happened at INMD last week (1201-1205)?
Weekly Report · 6d ago
Weekly Report: what happened at INMD last week (1124-1128)?
Weekly Report · 12/01 10:10
Weekly Report: what happened at INMD last week (1117-1121)?
Weekly Report · 11/24 10:15
Noteworthy ETF Inflows: AVDV, CSTM, MRX, INMD
NASDAQ · 11/17 15:47
Weekly Report: what happened at INMD last week (1110-1114)?
Weekly Report · 11/17 10:15
There Might Be More To InMode's (NASDAQ:INMD) Story Than Just Weak Earnings
Simply Wall St · 11/12 18:54
Weekly Report: what happened at INMD last week (1103-1107)?
Weekly Report · 11/10 10:12
How Softer Q3 Results and Leadership Changes at InMode (INMD) Have Changed Its Investment Story
Simply Wall St · 11/07 17:57
Barclays Remains a Buy on InMode (INMD)
TipRanks · 11/07 09:37
InMode Is Maintained at Neutral by UBS
Dow Jones · 11/06 18:52
InMode Price Target Cut to $16.00/Share From $16.25 by UBS
Dow Jones · 11/06 18:52
UBS Maintains Neutral on InMode, Lowers Price Target to $16
Benzinga · 11/06 18:45
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD), InMode (INMD) and Pennant Group (PNTG)
TipRanks · 11/06 14:40
InMode price target lowered to $16 from $16.25 at UBS
TipRanks · 11/06 13:30
InMode (INMD) Gets a Hold from UBS
TipRanks · 11/06 13:08
Analysts Offer Insights on Healthcare Companies: RxSight (RXST) and InMode (INMD)
TipRanks · 11/06 12:50
InMode (INMD) Profit Margin Surges to 44.5%, Reinforcing Bullish Narratives on Value and Growth
Simply Wall St · 11/06 05:48
InMode’s Q3 2025 Financial Results Overview
TipRanks · 11/06 04:01
InMode’s Earnings Call: Mixed Sentiments Amid Growth
TipRanks · 11/06 00:04
More
Webull provides a variety of real-time INMD stock news. You can receive the latest news about Inmode Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About INMD
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.